Remote amide bonds in simple N-acyl
amino acid amide or peptide
derivatives 1 can be surprisingly unstable hydrolytically,
affording, in solution, variable amounts of 3 under mild
acidic conditions, such as trifluoroacetic acid/water mixtures at
room temperature. This observation has important implications for
the synthesis of this class of compounds, which includes N-terminal-acylated
peptides. We describe the factors contributing to this instability
and how to predict and control it. The instability is a function of
the remote acyl group, R2CO, four bonds away from the site
of hydrolysis. Electron-rich acyl R2 groups accelerate
this reaction. In the case of acyl groups derived from substituted
aromatic carboxylic acids, the acceleration is predictable from the
substituent’s Hammett σ value. N-Acyl dipeptides are
also hydrolyzed under typical cleavage conditions. This suggests that
unwanted peptide truncation may occur during synthesis or prolonged
standing in solution when dipeptides or longer peptides are acylated
on the N-terminus with electron-rich aromatic groups. When amide hydrolysis
is an undesired secondary reaction, as can be the case in the trifluoroacetic
acid-catalyzed cleavage of amino acid amide or peptide derivatives 1 from solid-phase resins, conditions are provided to minimize
that hydrolysis.
Efficient
syntheses of chiral fragments derived from chiral amino
alcohols are described. Several unique scaffolds were readily accessed
in 1–5 synthetic steps leading to 45 chiral fragments, including
oxazolidinones, morpholinones, lactams, and sultams. These fragments
have molecular weights ranging from 100 to 255 Da and are soluble
in water (0.085 to >15 mM).
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.